Trading Halt
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/trading-halt-817
Trading in the securities of Oncosil Medical Ltd (‘OSL’) will be halted at the request of OSL, pending the release of an announcement by OSL. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of: • the commencement of normal trading on Tuesday, 3 February 2026; or • the release of the announcement to the market. OSL’s request for a trading halt is attached
Earlier from OncoSil Medical
- OncoSil receives $1.84m R&D tax incentive
- OSPREY Analysis Shows Survival Benefit for OncoSil Patients
- Response to ASX Aware Letter
- Positive Preliminary Results from PANCOSIL Phase 1-2 Study
- Appendix 4E and Annual Report
Later from OncoSil Medical
- Quarterly Activities/Appendix 4C Cash Flow Report
- $8.0 million Capital Raise for Ongoing Commercial Expansion
- Prospectus
- Capital Raising Presentation
- CEO Remuneration Update
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical